A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. 1995

J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
CNRS EP 10, INSERM U358, Hôpital Saint-Louis, Paris, France.

Non-insulin-dependent diabetes mellitus (NIDDM) affects about 5% of the world population. The disease presents a polygenic mode of inheritance, but mechanisms and genes involved in late-onset NIDDM are largely unknown. We report the association of a single heterozygous Gly to Ser missense mutation in the glucagon receptor gene with late-onset NIDDM. This mutation was highly associated with NIDDM in a pooled set of French and Sardinian patients (chi 2 = 14.4, P = 0.0001) and showed some evidence for linkage to diabetes in 18 sibships from 9 French pedigrees (chi 2 = 6.63, P < 0.01). Receptor binding studies using cultured cells expressing the Gly40Ser mutation demonstrate that this mutation results in a receptor which binds glucagon with a three-fold lower affinity compared to the wild type receptor.

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
May 1996, Diabetes research and clinical practice,
J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
October 1998, Zhonghua yi xue za zhi,
J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
January 2000, Chinese medical journal,
J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
January 1997, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
April 1995, Biochemical and biophysical research communications,
J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
July 1999, Clinical chemistry and laboratory medicine,
J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
May 1993, Diabetologia,
J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
April 1991, Diabetologia,
J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
February 1984, Diabetes,
J Hager, and L Hansen, and C Vaisse, and N Vionnet, and A Philippi, and W Poller, and G Velho, and C Carcassi, and L Contu, and C Julier
January 1987, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!